ProKidney reports larger loss in 2024 as production resumes
ProKidney Corp. reported Friday a $61.2 million loss in fiscal 2024 as the biotechnology company resumed production and retrenched its growth plans to its Winston-Salem facilities.…
ProKidney Corp. reported Friday a $61.2 million loss in fiscal 2024 as the biotechnology company resumed production and retrenched its growth plans to its Winston-Salem facilities.…